Preventive effects of Cyclosporin on diabetes in NOD mice

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Diabetologia

• Publication date

  1986-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00454884PMID 3519340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects of cyclosporin A: A new antilymphocytic agent

  2005cited by this paper
• Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.

  1985cited by this paper
• Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.

  1984cited by this paper
• Cyclosporin prevents diabetes in BB Wistar rats.

  1983cited by this paper
• Skin grafts in rabbits with cyclosporin A: absence of induction of tolerance and untoward side effects.

  1981cited by this paper
• PROLONGATION OF RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH DONOR ANTIGEN AND CYCLOSPORIN A

  1981cited by this paper
• Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.

  1980cited by this paper
• Use of cyclosporin A in allogeneic bone marrow transplantation in the rat

  1979cited by this paper
• Rapid and sensitive, colorimetric determination of the anomers of D-glucose with D-glucose oxidase, peroxidase, and mutarotase.

  1977cited by this paper
• Biological effects of cyclosporin A: A new antilymphocytic agent

  1976cited by this paper

• From pre-clinical efficacy to promising clinical trials that delay Type 1 diabetes.

  2024cites this paper
• Contribution of animal models to diabetes research: Its history, significance, and translation to humans

  2023cites this paper
• Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca2+ mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration

  2021cites this paper
• Characterization of a mouse model of islet transplantation using MIN-6 cells

  2020cites this paper
• Regulators of Beta-Cell Death and Regeneration

  2016cites this paper
• The Roles of Iddm30 and Iddm24 in the Immunopathogenesis of Type 1 Diabetes in BioBreeding Rats

  2015cites this paper
• Recombinant Human Tumor Necrosis Factor a Suppresses Autoimmune Diabetes in Nonobese Diabetic Mice

  2013cites this paper
• Function of the immunoregulatory CD4-CD8- T cells in the context of autoimmune diabetes

  2013cites this paper
• Diabetogenic T Cells from Transgenic Decarboxylase 65 Sequence, that Stimulate Peptide Ligands, Including a Glutamic Acid Identification of MHC Class II-Restricted

  2013cites this paper
• Association between immune reactivity and disease status of type 1, type 2 diabetes and latent autoimmune diabetes in adults

  2011cites this paper
• Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis.

  2011cites this paper
• Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus

  2010cites this paper
• Immunotherapy of type 1 diabetes: where are we and where should we be going?

  2010cites this paper
• Vitamin D and diabetes.

  2010cites this paper
• AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice

  2009cites this paper
• Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse.

  2007cites this paper
• Targeting JAK3 tyrosine kinase-linked signal transduction pathways with rationally-designed inhibitors.

  2007cites this paper
• Preventive and Therapeutic Potential of p38α-Selective Mitogen-Activated Protein Kinase Inhibitor in Nonobese Diabetic Mice with Type 1 Diabetes

  2006influential citation
• Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors.

  2006cites this paper
• CHAPTER 99 – Vitamin D and Diabetes

  2005cites this paper
• A comprehensive review of interventions in the NOD mouse and implications for translation.

  2005cites this paper
• The NOD mouse: a model of immune dysregulation.

  2005cites this paper
• Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosasignal molecule, N-(3-oxododecanoyl)-L-homoserine lactone

  2005cites this paper
• Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial

  2005cites this paper
• THE NOD MOUSE: AM odel ofImmune Dysregulation

  2005cites this paper
• Immunomodulation through inhibition of multiple adhesion molecules generates resistance to autoimmune diabetes in NOD mice.

  2004cites this paper
• 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis.

  2004cites this paper
• Human pancreatic duct cells can produce tumour necrosis factor-α that damages neighbouring beta cells and activates dendritic cells

  2004cites this paper
• Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases.

  2004cites this paper
• Rat models of type 1 diabetes: genetics, environment, and autoimmunity.

  2004cites this paper
• Treatment of type 1 diabetes mellitus to preserve insulin secretion.

  2004cites this paper
• Therapeutic potential of Janus kinase 3 (JAK3) inhibitors.

  2004cites this paper
• Treatment of type 1 diabetes with anti-T-cell agents: From T-cell depletion to T-cell regulation

  2004cites this paper
• Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

  2004cites this paper
• REVIEW Central role of defective apoptosis in autoimmunity

  2003cites this paper
• Central role of defective apoptosis in autoimmunity.

  2003cites this paper
• Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.

  2003cites this paper
• Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases

  2002cites this paper
• Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1

  2001cites this paper
• Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere.

  2001cites this paper
• Immunotherapy of immune-mediated diabetes

  2000cites this paper
• Effect of gliotoxin on development of diabetes mellitus in diabetes-prone BB/Wor rats.

  2000cites this paper
• Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin.

  2000cites this paper
• Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system.

  2000cites this paper
• IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.

  1999cites this paper
• Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

  1999cites this paper
• Minute Defects in the Expression of MHC E Molecules Lead to Impaired Protection from Autoimmunity in NOD Mice

  1999cites this paper
• Type 1 diabetes: the facts fit a deficient inhibitory signal given by MHC Class II

  1999cites this paper
• Effects of BCG, lymphotoxin and bee venom on insulitis and development of IDDM in non-obese diabetic mice.

  1999cites this paper
• Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.

  1998cites this paper
• Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A.

  1998cites this paper
• Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice.

  1997cites this paper
• New aspects to the functioning and regeneration of pancreatic beta-cells. Cyclic ADP-ribose and Reg gene.

  1997cites this paper
• Prevention of onset in an insulin‐dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei

  1997cites this paper
• Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases

  1997cites this paper
• A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.

  1997cites this paper
• Linomide increases plasma corticosterone in normal rats, but does not prevent the inhibitory action of IL-1 on beta-cells in vivo or ex vivo.

  1996cites this paper
• The role of interleukin-1 in the pathogenesis of IDDM

  1996cites this paper
• Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.

  1996cites this paper
• Oral Tolerance to Insulin and the Insulin B‐Chain.

  1996cites this paper
• Cyclosporin depresses pancreatic islet expression of antigens for islet cell autoantibodies in non obese diabetic mice.

  1996cites this paper
• Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A.

  1996cites this paper
• Influence of T lymphocytes and major histocompatibility complex class II genes on diabetes susceptibility in the NOD mouse.

  1996cites this paper
• Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.

  1995cites this paper
• LING ZHI‐8: STUDIES OF A NEW IMMUNOMODULATING AGENT

  1995cites this paper
• T helper cell subsets in insulin-dependent diabetes.

  1995cites this paper
• Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.

  1995cites this paper
• Homing of lymphocytes into islets of Langerhans in prediabetic non-obese diabetic mice is not restricted to autoreactive T cells.

  1995cites this paper
• Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised.

  1995cites this paper
• Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificity.

  1995cites this paper
• Evidence of CD4 + regulatory T cells in the non-obese diabetic male mouse

  1994cites this paper
• Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

  1994cites this paper
• Hormonal and other mechanisms involved in the pathogenesis of cyclosporin-induced nephrotoxicity and hypertension in man.

  1994cites this paper
• Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus.

  1994cites this paper
• Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease.

  1994cites this paper
• Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD mice.

  1994cites this paper
• Neonatal injections of cyclosporin enhance autoimmune diabetes in non‐obese diabetic mice

  1994cites this paper
• Prediction and prevention of type I diabetes

  1994cites this paper
• Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice.

  1994cites this paper
• Modifications of the expression of homing and adhesion molecules in infiltrated islets of Langerhans in NOD mice.

  1994cites this paper
• Studies on the thymus of non-obese diabetic (NOD) mice: effect of transgene expression.

  1994cites this paper
• Isolation of Nonobese Diabetic Mouse T-Cells That Recognize Novel Autoantigens Involved in the Early Events of Diabetes

  1994cites this paper
• Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

  1994cites this paper
• BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.

  1994cites this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cites this paper
• Effects of Orally Administered Rapamycin in Animal Models of Arthritis and Other Autoimmune Diseases

  1993cites this paper
• Strategies in Immunotherapy of Insulin‐Dependent Diabetes Mellitus

  1993cites this paper
• Lymph Node T-Cells Do Not Optimally Transfer Diabetes in NOD Mice

  1993cites this paper
• Analysis of VH gene utilisation in the non-obese diabetic mouse.

  1993cites this paper
• Effect of STZ Administration on Islet Isograft and Allograft Survival in NOD Mice

  1993cites this paper
• Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice.

  1993cites this paper
• Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506.

  1993cites this paper
• Immunosuppressive therapy of autoimmune diseases.

  1993cites this paper
• Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

  1993cites this paper
• Establishment of T-cell lines from infiltrated NOD islets by stimulation of specific T-cell receptor V beta segments.

  1993cites this paper
• Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice

  1993cites this paper
• Immunosuppressive therapy of autoimmune diseases.

  1993cites this paper
• Prevention of type I diabetes with lymphotoxin in BB rats.

  1993cites this paper
• Antioxidant MDL 29,311 Prevents Diabetes in Nonobese Diabetic and Multiple Low-Dose STZ-Injected Mice

  1993cites this paper
• Prevention of Autoimmune Diabetes with Lymphotoxin in NOD Mice

  1993cites this paper